Ziopharm Oncology to Present at the BofA Securities 2020 Health Care Conference

NEXT STORY
Enteral Feeding Devices Market to surpass US$ 5.0 Bn globally by end of 2027 – Coherent Market Insights
PREV STORY
FDA Grants Fast Track Designation for Omecamtiv Mecarbil in Heart Failure
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Phase III data showed that Venclexta/Venclyxto plus Gazyva/Gazyvaro reduced the risk of disease worsening or death in people with previously untreated chronic lymphocytic leukaemia with co-morbidities

The phase III CLL14 study compared Venclexta/Venclyxto in combination with Gazyva/Gazyvaro to standard-of-care Gazyva/Gazyvaro ...

author_avatar
NASDAQ Market News

Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant

8 June 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first ...

author_avatar
NASDAQ Market News

Global proteomics market is expected to undergo a healthy growth during the forecast period and is projected to reach USD66.59 billion by 2026

author_avatar
NASDAQ Market News